Related Experiment Video
Updated: Nov 11, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Hormone Replacement Therapy and Development of New Asthma
Erik Soeren Halvard Hansen1, Kristian Aasbjerg2, Amalie Lykkemark Moeller3
1Centre for Physical Activity Research, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Hormone replacement therapy (HRT) may increase the risk of new asthma diagnoses in women aged 40-65. Discontinuing HRT might also lead to stopping asthma treatment.
Area of Science:
- Reproductive endocrinology
- Pulmonology
- Pharmacoepidemiology
Background:
- Hormone replacement therapy (HRT) is widely used by women globally.
- Existing research presents conflicting evidence on HRT's effects on asthma, suggesting both protective and harmful impacts.
Purpose of the Study:
- To investigate the association between hormone replacement therapy (HRT) and the new development of asthma in menopausal women.
Main Methods:
- A nested case-control study utilized Danish health registers from 1995 to 2018.
- Asthma diagnosis was established by two inhaled corticosteroid prescriptions within two years.
- HRT was defined by two female sex hormone prescriptions within six months.
Main Results:
- Active HRT was associated with a 1.63-fold increased hazard of new asthma development in women aged 40-65.
- Women with asthma who stopped HRT were more likely to discontinue their asthma medication (HR 2.12).
Conclusions:
- Hormone replacement therapy appears to influence asthma development in mature women.
- Healthcare providers and patients should consider the potential for new respiratory symptoms and the option of HRT discontinuation.
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-I: Introduction
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Nursing Management
First, in...
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...

